Advances in pancreas transplantation

Transplantation

Volumn 77, Issue 9, 2004, Pages

  Burke, George W ^a   Ciancio, Gaetano ^a   Sollinger, Hans W ^b  

^a JACKSON MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; STEROID; T LYMPHOCYTE ANTIBODY; TACROLIMUS;

ACNE; FRACTURE; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MENTAL DISEASE; NEPHROTOXICITY; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; STEROID THERAPY; XENOTRANSPLANTATION;

EID: 2442695175     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000126929.71923.77     Document Type: Review

References (45)

1. Odorico JS, Sollinger HW. Technical and immunosuppressive advances in transplantation. World J Surg 2002; 26: 194.
2. Auchincloss H, Shaffer D. Pancreas transplantation. In: Ginns LC, Cosimi AB, Morris PJ, eds. Transplantation. Malden, MA, Blackwell Science Inc 1999.
3. Burke GW III, Kaufman DB, Millis M. Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas kidney transplantation: 3 year results. Transplantation 2004; 77: 1269.
4. Sutherland DER, Gores PF, Farney AC, et al. Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg 1993; 166: 456-491.
5. Lillehei RC, Simmons RL, Najarian JS, et al. Pancreaticoduodenal allotransplantation: experimental and clinical experience. Ann Surg 1970; 172: 405.
6. Lillehei RC, Ruiz JO, Aquino C, et al. Transplantation of the pancreas. Acta Endocrinol (Copenh) 1976; 83(suppl 205): 303.
7. Sutherland DE, Gruessner RW, Gruessner AC. Pancreas transplantation for treatment of diabetes mellitus. World J Surg 2001; 25(4): 487.
8. Gruessner RW, Burke GW, Stratta R, et al. A multicenter, analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 1996; 61: 261.
9. Dunn CJ, Wagstaff AJ, Perry CM, et al. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy, and tolerability of a microemulsion-based formulation (Neoral)1 in organ transplantation. Drugs 2001; 61(13): 1957.
10. Vanrenterghem Y, Malaise J, Morel P, EUROSPK Study Group. Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney (SPK) transplantation: results at 1 year of a large multicenter trial [abstract]. From the Proceeding of the International Transplant Society Congress, August 2002, Miami, FL.
11. Gruessner RW, Sutherland DE, Najarian JS, et al. Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus. Transplantation 1997; 64: 1572.
12. Hariharan S, Munda R, Cavallo T, et al. Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity. Transplantation 1996; 61: 1161.
13. Odorico JS, Becker YT, Groshek M, et al. Improved solitary pancreas transplant graft survival in the modern immunosuppressive era. Cell Transplant 2000; 9(6): 919.
14. Corry RJ, Egidi MF, Shapiro R, et al. Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. Transplant Proc 1998; 30(2): 521.
15. Gruessner AC, Sutherland DE. Analysis of United States (US) and non-US pancreas transplants as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). In: Cecka JM, Terasaki PI, eds. Clinical transplantation 1997. Los Angeles, UCLA Tissue Typing Laboratory 1998, pp. 45-59.
16. Gruessner AC, Sutherland DE. Analysis of United States (US) and non-US pancreas transplants as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). In: Cecka JM, Terasaki PI, eds. Clinical transplantation 1998. Los Angeles, UCLA Tissue Typing Laboratory 1998, p. 53-71.
17. Gruessner A, Sutherland DE. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Sharing (UNOS) and non-US cases reported to the International Transplant Registry (IPTR) as of October, 2000. Clinical transplantation 2001. Los Angeles, UCLA Tissue Typing Laboratory 2002. P. 45.
18. Jordan ML, Shapiro R, Gritsch HA, et al. Long-term results of pancreas transplantation under tacrolimus immunosuppression. Transplantation 1999; 67(2): 266.
19. Morrissey PE, Gohh R, Shaffer D, et al. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Transplantation 1997; 63(6): 845.
20. Elmer DS, Nyman T, Hathaway DK, et al. Use of FK506 immunosuppressive therapy in pancreas transplantation. J Transpl Coord 1996; 6(3): 122.
21. Shapiro AM, Suarez-Pinzon WL, Power R, et al. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. Diabetologia 2002; 45(2): 224.
22. Miyagawa J, Yamamoto K, Hanafusa T, et al. Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice. Diabetologia 1990; 33(8): 503.
23. Jindal RM, Sidner RA, Milgrom ML. Post-transplant diabetes mellitus. The role of immunosuppression. Drug Safety 1997; 16(4): 242.
24. Shen CN, Seckl JR, Slack JM, et al. Glucocorticoids suppress beta-cell development and induce hepatic metaplasia in embryonic pancreas. Biochem J 2003; 375(pt 1): 41.
25. Humar A, Kandaswamy R, Granger D, et al. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000; 231(2): 269.
26. Jordan ML, Chakrabarti P, Luke P, et al. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. Transplantation 2000; 69(2): 265.
27. Gruessner RW, Sutherland DE, Parr E, et al. Steroid withdrawal after pancreas transplantation (Pa Tx): a prospective, randomized, open-label study [abstract]. From the Proceedings of the International Transplant Society Congress, August 2002, Miami, FL.
28. Kaufman DB, Leventhal JR, Kofrron AJ, et al. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2002; 73: 169.
29. Stratta RJ, Lo A, Shokouh-Amiri MH, et al. Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression. Transpl Int 2003; 16(3): 154.
30. Bartlett ST, Schweitzer EJ, Johnson LB, et al. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation: a prospective trial of tacrolimus immunosuppression with percutaneous biopsy. Ann Surg 1996; 224: 440.
31. Gruber SA, Katz S, Kaplan B, et al. Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. Transplantation 2000; 70(2): 388.
32. Gruessner AC, Sutherland DE. Analysis of United States (US) and non-US pancreas transplants as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). In: Cecka JM, Terasaki PI, eds. Clinical transplantation 1997. Los Angeles, UCLA Tissue Typing Laboratory 1998, pp. 45-59.
33. Krieger NR, Odorico JS, Heisey DM, et al. Underutilization of pancreas donors. Transplantation 2003; 75(8): 1271.
34. Bottino R, Trucco M, Balamurugan AN, et al. Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol 2002; 16(3): 457.
35. Hartgrink HH, van Bockel JH, Hansen B, et al. Effect of blood group and HLA matching on pancreas graft survival with the use of UW solution. Transpl Int 1995; 8(5): 366.
36. Pfeffer F, Nauck MA, Drognitz O, et al. Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than years after pancreas-kidney transplantation. Transplantation 2003; 76(10): 1427.
37. Hopt UT, Drognitz O. Pancreas organ transplantation: short and long-term results in terms of diabetes control. Langenbecks Arch Surg 2000; 385(6): 379.
38. Burke GW, Ciancio G, Olson L, et al. Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression. Transplant Proc 2001; 33(1-2): 1681.
39. Humar A, Khwsja K, Ramcharan T, et al. Chronic rejection: the next major challenge for pancreas transplant recipients. Transplantation 2003; 76: 918.
40. Vendstrom JM, McBride MA, Rother KI, et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290(21): 2817.
41. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
42. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton Protocol. Diabetes 2001; 50: 710.
43. Brendel, Hering BJ, Schultz AO, et al. International Islet Transplant Registry: update of worldwide human islet transplantations [abstract]. From the Proceedings of the International Transplant Society Congress, August 2002, Miami, FL.
44. National Diabetes Information Clearinghouse. Pancreatic islet transplantation. Available at: http://diabetes.niddk.nih.gov/dm/pubs/pancreaticislet/index.htm. Accessed January 8, 2004.
45. Goss JA, Schock AP, Brunicardi FC, et al. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation 2002; 74(12): 1761.